UnitedHealth Group Incorporated (UNH) — closed signal from January 1, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on April 1, 2026.
Predicted vs. what happened
What happened
Reached its target in 22 days.
The thesis — published January 1, 2026
UnitedHealth is seen as a safer pick in healthcare but news about expiring subsidies and possible big premium increases can scare investors. That news can push the whole insurance group lower even if UnitedHealth is stabilizing. Expect slow, steady gains rather than a fast jump; avoid large positions when policy headlines are uncertain.
Primary drivers
- Seen as safer in market swings, so investors may move here when worried
- Good media attention can bring more buying interest in the short term
- Government policy changes can quickly change how people view insurers
- Price is settling slowly, so gains are likely to be cautious and steady
How it played out
UNH: target reached in 22 days
Lyra published UNH at $330.11 on 2026-01-01 with expected growth of 8%. The thesis pointed to UnitedHealth as a safer healthcare pick, but also warned that subsidy and premium headlines could scare investors. It expected slow, steady gains rather than a fast jump.
Inside the window, UNH reached the $356.52 target. The peak was $357.87 on 2026-01-23, a 8.4% gain, and the target was reached in 22 days. It did not hold those gains through the end. The stock finished the window at $273.98 on 2026-04-01. Verdict: the target thesis played out, but the later path did not stay steady.
What happened during the window
On 2026-01-27, UnitedHealth reported fourth-quarter 2025 results and gave 2026 revenue guidance of more than $439 billion, according to MarketWatch. On the same date, CMS proposed a 0.09% payment increase for 2027 Medicare Advantage plans, according to MarketWatch.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.